BCL2 gene polymorphisms and splicing variants in chronic myeloid leukemia
- 1 November 2015
- journal article
- Published by Elsevier in Leukemia Research
- Vol. 39 (11), 1278-1284
- https://doi.org/10.1016/j.leukres.2015.08.014
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- Isoform level expression profiles provide better cancer signatures than gene level expression profilesGenome Medicine, 2013
- Quantification of BCR-ABL mRNA in Plasma/Serum of Patients with Chronic Myelogenous LeukemiaInternational Journal of Medical Sciences, 2012
- Prognostic impact of polymorphisms in the MYBL2 interacting genes in breast cancerBreast Cancer Research and Treatment, 2011
- WT1 Synonymous Single Nucleotide Polymorphism rs16754 Correlates With Higher mRNA Expression and Predicts Significantly Improved Outcome in Favorable-Risk Pediatric Acute Myeloid Leukemia: A Report From the Children's Oncology GroupJournal of Clinical Oncology, 2011
- The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR ExperimentsClinical Chemistry, 2009
- SNPnexus: a web database for functional annotation of newly discovered and public domain single nucleotide polymorphismsBioinformatics, 2008
- Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memoryProceedings of the National Academy of Sciences, 2007
- Association of a novel regulatory polymorphism (−938C>A) in the BCL2 gene promoter with disease progression and survival in chronic lymphocytic leukemiaBlood, 2006
- Molecular Monitoring of Chronic Myelogenous LeukemiaThe Journal of Molecular Diagnostics, 2006
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001